PROCESSES FOR PREPARING CRYSTALLINE FORMS
The present invention relates to intermediates and their preparation, for use in the manufacture of pure dasatinib, in particularly dasatinib monohydrate and anhydrous dasatinib. The invention also relates to pharmaceutical compositions comprising pure dasatinib and their use in the treatment of can...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to intermediates and their preparation, for use in the manufacture of pure dasatinib, in particularly dasatinib monohydrate and anhydrous dasatinib. The invention also relates to pharmaceutical compositions comprising pure dasatinib and their use in the treatment of cancer.
L'invention concerne des intermédiaires et leur élaboration, aux fins d'utilisation dans la fabrication de dasatinib pur, en particulier le monohydrate de dasatinib et le dasatinib anhydre. L'invention concerne aussi des compositions pharmaceutiques renfermant du dasatinib pur et leur utilisation dans le traitement du cancer. |
---|